SINGAPORE (May 15): Specialty pharmaceutical firm iX Biopharma on Monday incorporated a new wholly-owned subsidiary in Singapore, Entity Health, to promote and market the group’s supplements business.

Entity is the group’s third business arm, and will complement its existing pharmaceuticals and chemical analysis businesses.

According to iX Biopharma, global supplements sales have increased by 50% from 2009 to US$88 billion ($123 billion) in 2014 as a result of the growth in demand for supplements in the consumer healthcare market.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook